Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis

https://doi.org/10.1016/j.jcf.2009.04.006Get rights and content
Under an Elsevier user license
open archive

Abstract

Background

Adaptive aerosol delivery (AAD) nebuliser devices can reduce treatment times whilst enabling adherence to be monitored using inbuilt data logs. Using one such device, we have monitored nebulised antibiotic adherence in children with Cystic Fibrosis (CF).

Methods

In CF children infected with Pseudomonas aeruginosa, downloaded data from an AAD device was used to calculate morning, evening and overall monthly adherence to antibiotic therapy over a year.

Results

Overall monthly adherence to nebulised antibiotic therapy in 28 children was maintained between 60 and 70% over the year. Considerable variation in adherence, both between and within patients, was evident (Mean [SD] coefficient of variation, 37[44]%). Evening adherence (75[37]%) was better than morning adherence (58[34]%: p = 0.012). Treatment regimens were changed in 8/28 patients based on adherence data.

Conclusions

Routine adherence monitoring can be implemented in an outpatient setting. Using this type of information it is possible to identify which aspects of treatment can be improved and to work together with families to individualise treatments.

Keywords

Adherence
Cystic fibrosis
Nebuliser
Adaptive aerosol delivery

Cited by (0)

Some of these data has been presented in the form of a poster at the European Cystic Fibrosis Conference in June 2007 in Belek, Turkey.